BioSpace News Archive

BioMidwest

Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS

Pasithea Therapeutics Corp. announced that it has selected a lead therapeutic candidate for its PAS-003 program, a proprietary humanized monoclonal antibody that targets α5β1 integrin, a protein found to be overexpressed in both human and mouse subjects with amyotrophic lateral sclerosis.

November 9, 2023
·
6 min read
Business

CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Inc. reported financial results for the third quarter ended September 30, 2023.

November 9, 2023
·
11 min read
Biotech Beach

Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery

Terray Therapeutics announced an equity investment by NVentures, NVIDIA’s venture capital arm.

November 9, 2023
·
2 min read
Antibe Reports PK Results of First Clinical Study of Otenaproxesul’s New Formulation

Antibe Therapeutics Inc. is pleased to announce the PK results of the pharmacokinetic/pharmacodynamic study of otenaproxesul’s faster-absorbing formulation.

November 9, 2023
·
3 min read
Business

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

LENSAR, Inc. announced financial results for the quarter ended September 30, 2023 and provided an update on key operational initiatives.

November 9, 2023
·
14 min read
Business

Xeris Biopharma Reports Third Quarter 2023 Financial Results

Xeris Biopharma Holdings, Inc. announced financial results for the third quarter and nine months ended September 30, 2023 and corporate highlights.

November 9, 2023
·
12 min read
Genetown

Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies

Elucid , a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding.

November 9, 2023
·
4 min read
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors

Apyx Medical Corporation today announced that the Company and its subsidiaries have entered into a new, five-year credit agreement with Perceptive Credit Holdings IV, LP (“Perceptive”), an affiliate of Perceptive Advisors.

November 9, 2023
·
6 min read
Business

Repare Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

Repare Therapeutics Inc today reported financial results for the third quarter ended September 30, 2023.

November 9, 2023
·
17 min read
Business

Ironwood Pharmaceuticals Reports Third Quarter 2023 Results

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its third quarter 2023 results and recent business performance.

November 9, 2023
·
32 min read